DNA

ORIC® Pharmaceuticals to Present Initial Data from Phase 1b Trial of ORIC-944 in Combination with Androgen Receptor Inhibitors in Patients with mCRPC

Conference Call and Webcast on Wednesday, May 28, 2025, at 4:30 p.m. ETSOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May…

7 months ago

MGI Tech Showcases Comprehensive Multi-Omics Solutions at ESHG 2025 Milan

MILAN, May 26, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies…

7 months ago

IMUNON Announces Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$3.25 million upfront with up to an additional $6.5 million of potential aggregate gross proceeds upon the exercise in full of…

7 months ago

Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer

BOSTON, May 21, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA, "Ginkgo" or the "Company"), which is building the leading platform for…

7 months ago

New Research Overturns Claim that Humans and Chimps Differ by Only 1% in Their DNA

SEATTLE, May 21, 2025 /PRNewswire/ -- For years, the public has been told that human beings and chimpanzees are, in…

7 months ago

Aeroflow Health Expands Lactation Coverage for Mothers Across Twelve States Through Medicaid

The durable medical equipment provider is continuing its mission of improving maternal health outcomes by now providing virtual lactation services…

7 months ago

Synfini Inc. and Multispan Announce Drug Discovery Collaboration 

Collaboration Combines Best-in-Class Biology with Agile AI and Chemistry Automation for Rapid Discovery of Better Molecules for Highly Valuable G…

7 months ago

ABLi Therapeutics Announces Details of the End of Phase 2 Meeting with FDA for Evaluation of Risvodetinib as a Treatment for Parkinson’s Disease

Agency supports primary and novel secondary and exploratory endpoints proposed for Phase 3 Trial(s) Opportunity to utilize time-to-delay of levodopa/carbidopa…

7 months ago

Konica Minolta Healthcare to Launch Integrated Teleradiology Solution Powered by NewVue

Exa Platform Konica Minolta Healthcare's Exa® Platform facilitates the viewing of large medical image files across the enterprise. TAMPA, Fla.…

7 months ago

Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study

Data from 250-patient, 31-center, randomized controlled trial presented at European Stroke Organisation Conference Three highest enrolling sites reported 96% delivery…

7 months ago